INTRODUCTION
Indian Psychiatric Society (IPS) published Clinical Practice Guidelines (CPGs) for management of dementia, in the year 2007. (http://www.indianjpsychiatry.org/cpg2007.asp). The current version of the CPG is an update of the earlier version of CPGs for management of dementia There were three separate CPGs for management of dementia ,one each for Reversible Dementias, Alzheimer's Disease and Vascular Dementia, Please note that the present CPG on dementia deals all types of dementia together. The current version of the CPGs for dementia in elderly must be read in conjunction with the previous version of CPGs for dementia. The focus of the present CPG is to provide suggestions and clinical tips to differentiate dementia syndrome from other clinical conditions, identify the subtypes of dementia and then offer suggestions for management .
These guidelines only provide a broad framework for assessment, management and follow-up of older people with dementia. While most of the recommendations are evidence based, these guidelines should not be considered as a substitute of professional knowledge and clinical judgment. The recommendations made as part of these guidelines should be tailored to address the clinical needs of the individual patient and the treatment setting.
AGING, DEPRESSION AND DEMENTIA
Before we examine the management of dementia, let us look at the issues related to the clinical diagnosis of dementia. Mental health problems and disablement are frequent in late life. Dementia and depression are two major mental health problems in late life . It is well known that the prevalence of dementia increases steadily with age. Normal aging itself is associated with age related decline in cognitive functions. Depressive symptoms are more common in later years of life. The differentiation between depressive disorder and a cognitive disorder can be problematic in this age group. There are many symptoms which can be seen in both in depressive disorders as well as in cognitive disorders. Depression can co-exist with mild cognitive impairment (MCI) a condition which is being increasingly recognized as an important entity.
Mild cognitive impairment (MCI) is a controversial entity but remains a useful construct in terms of targeting interventions to prevent dementia. MCI detection relies largely on subjective memory complaint (SMC) as a presenting symptom. However SMC is heterogeneous in its etiology and poorly predicts medium-term dementia risk. The differentiation of early dementia from MCI depends on the level of cognitive impairment and the resultant disability. Cognitive impairment in dementia causes significant impairment in instrumental activities of daily living and this is known to increase with time. Most diagnostic criteria use the resultant disability as an important differentiating feature. However reliance on informant reports can be problematic as that could be influenced by the social context , expectations of the informant and his or her ability to know and the current level of functioning of the older person. of dementia and differentiating it from other cognitive disorders is the first task. Other assessments can then follow. The suggested assessments are best carried out as part of the initial evaluation though it might take a few sessions to complete. See table -1 . 1) Look for signs and symptoms of dementia 2)
Rule out DELIRIUM, DEPRESSION 3)
Look for other Medical Problems 4)
Assess Cognitive Symptoms 5)
Assess Non-Cognitive (Behavioural) and Psychological Symptoms 6) Rule out other Mental Health or Substance use disorders 7)
Assess care arrangements and needs of carers
The following assessments will help in making a clinical diagnosis of dementia : See the flow chart below.
Figure 1: Initial assessment

History of Cognitive Changes
History taking is the main tool in eliciting and evaluating the nature and progression of cognitive decline. Choose an informant who knows about the person's current and past personal ,social and occupational functioning . A reliable informant should be interviewed separately in person. This will allow discussion of a certain information which may otherwise be difficult in the presence of the patient. While doing the assessments, one has to be mindful of the family's culture, values, primary language, literacy level and also the decision making process. A thorough history should include details like the mode of onset of cognitive decline which affects multiple cognitive domains. The pattern progression, clinical manifestations of cognitive dysfunction, behavioral as well as personality changes will have to be enquired into.
Subjects or informants can be asked if the person is forgetful about recent events ;especially amnesia for events which happened hours or days back. Does the person forget the fact that he/she had a meal some time after having the meal? Does the person tend to ask the same questions repeatedly even though this was answered many times. Is the person unable to recall where they've placed things and often searching for things? A review of current medication is very important. Enquire if there is worsening of cognitive symptoms after initiation of a certain new medication. Details regarding the use of all medications, including over-the-counter products, may be collected .See if the person is on medications with anti-cholinergic effects which can worsen cognitive functions.
Importance of Identification of Delirium
Delirium is an important differential diagnosis of dementia .Patients with pre-existing dementia could present for the first time with superimposed delirium. Sudden worsening of cognitive functions and appearance of behavioural symptoms should alert the clinician to the possibility of delirium. Delirium is a medical emergency signs that needs to be identified early and evaluated immediately.
A diagnosis of dementia cannot be made if the cognitive deficits occur exclusively during the course of delirium .Delirium is characterized by a disturbance of consciousness and a change in cognition that develop over a short period of time. The disorder has a tendency to fluctuate during the course of the day, and there is evidence from the history, examination or investigations that the delirium is a direct consequence of a general medical condition, substance intoxication or withdrawal.
The ICD 10 diagnostic criteria for Delirium is given below Clinician should take care, not to misdiagnose Delirium as Dementia and also not to miss the diagnosis of Delirium when it is superimposed on dementia. When there is clinical suspicion of delirium, the efforts should focus on identifying the causes. Delirium in older people are most often multifactorial in etiology and identification of the underlying conditions would enable us to provide interventions to reverse/modify them. The evaluations need to be comprehensive so that all common causes can be ruled out. Prolonged delirium could lead to more neuronal damage and accelerate cognitive decline by impacting the cognitive reserve
The interface between Delirium & Dementia
Delirium and dementia are two major causes for cognitive impairment in later years of life. Though these two conditions had been conceptualized as distinct , mutually exclusive entities ,it can be difficult at times to differentiate between them. Delirium in late life is often superimposed on pre-existing dementia and can be the reason for help seeking. Dementia is the leading risk factor for delirium in an older person. Occurrence of delirium in turn is a risk factor for subsequent dementia in older people without pre-existing dementia. The clinician needs to differentiate between three possible scenarios namely Delirium with no features suggestive of pre-existing dementia dementia with no features suggestive of delirium dementia with superimposed delirium . See table-2 for broad guidelines for making this distinction, which by no means, will be easy in a given clinical setting . When faced with uncertainty, it is better to attribute the symptoms to delirium and manage it as delirium.This will allow careful monitoring and detailed evaluation to identify modifiable conditions/factors. 
Differentiation between Dementia and Mild Cognitive Impairment
The differentiation between early dementia and mild cognitive impairment can be difficult at times but efforts to make that distinction is always warranted. DSM 5 uses the term Mild Neurocognitive Disorder to refer to this condition. ICD 10 does not have specific criteria. The following DSM 5 criteria may be used as a guide for clinical diagnosis of Mild Cognitive Impairment.
DSM 5 criteria for Mild Cognitive Impairment
A. Evidence of modest cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual motor, or social cognition) based on: 1. Concern of the individual, a knowledgeable informant, or the clinician that there has been a mild decline in cognitive function; and 2. A modest impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment.
B. The cognitive deficits do not interfere with capacity for independence in everyday activities (i.e., complex instrumental activities of daily living such as paying bills or managing medications are preserved, but greater effort, compensatory strategies, or accommodation may be required). C. The cognitive deficits do not occur exclusively in the context of a delirium. D. The cognitive deficits are not better explained by another mental disorder (e.g., major depressive disorder, schizophrenia).
Behavioral disturbance (e.g., psychotic symptoms, mood disturbance, agitation, apathy, or other behavioral symptoms
The diagnostic challenge in MCI here is in the assessment of "significant impairment in functional ability," which is required for the diagnosis of dementia. There is also the controversy about the best way to objectively measure memory loss. Early recognition of the condition may help the clinician to monitor the progression of cognitive and other symptoms and the later conversion to dementia. This might allow potential use of evidence based preventive interventions as and when they become available.The recognition of MCI as a diagnostic allows us to have a better understanding of the nature of mild memory loss ,which is far more common than dementia among the older segments of the population. Table-4 lists out the main differences between the two clinical conditions 
Assessment of Dementia Syndrome
We need to rule out delirium and mild cognitive disorder before we make a clnical diagnosis of dementia . Then one should apply and see if the person meets the diagnostic criteria for Dementia. If that is met, then there is a need to make further evaluations. The next part of evaluation is aimed at establishing the cause for the dementia syndrome.
Types and Causes of Dementia
Dementia is a syndrome which can be caused by many diseases .After the clinical recognition of dementia syndrome, the evaluations shall focus on identifying the cause of dementia. Causes can be broadly classified as "reversible causes' and "Irreversible" causes .Though "Reversible" causes are less frequent, they carry good prognosis with prompt treatment of the underlying condition. Thus the evaluation for all potentially reversible conditions which cause dementia syndrome is the first most important step in the assessment of dementia syndrome and this is essential in all cases presenting with features of dmentia. The type of investigations can be decided based on the clinical features and context of care. This aspect is discussed in detail in the 2009 Dementia Supplement of Indian Journal of Psychiatry.
Clinical Assessment
Patients who seek help in clinical settings often do not represent cases prevalent in the community. Reversible causes thus may be much more common in clinical settings than in community settings. Routine investigations should include complete blood count, erythrocyte sedimentation rate, and serum/blood levels of urea, electrolytes, calcium and phosphate, liver, renal and, thyroid function tests, urine analysis, VDRL and Serum B l2 ,and Folate levels. CT scan or MRI scan, at times, can be a very useful investigation in the differential diagnosis of dementia. Investigations for testing the HIV status, ECG, Chest radiograph, Electroencephalogram, Neuropsychological assessment etc are investigations worth considering. Dementia syndrome is linked to many underlying causes and diseases of the brain. The most common causes accounting for vast majority of cases are due to Alzheimer's disease, Vascular dementia, Dementia with Lewy Bodies and Frontotemporal dementia. After detailed assessment usually, the clinician would be in a position to judge the cause of the dementing illness. However at times, even the distinction between Vascular Dementia and Alzheimer's Disease (AD) may appear difficult. Clinical recognition of the subtypes of dementia is important and is easier during the early part of the illness. The differentiation between Lewy Body Dementia (LBD), Frontotemporal Dementia (FTD) and AD can be attempted during the initial evaluations itself. Such differentiation is feasible in clinical practice by using clinical criteria for these subtypes.
The clinicians might choose any standard criteria for making clinical diagnosis of dementia ,especially common sub-types. See Table 6 for the criteria which may be useful in clinical practice 
G1. Evidence of each of the following:
(1) A decline in memory, which is most evident in the learning of new information, although in more severe cases, the recall of previously learned information may be also affected. The impairment applies to both verbal and non-verbal material. The decline should be objectively Severe: a degree of memory loss characterized by the complete inability to retain new information. Only fragments of previously learned information remain. The subject fails to recognize even close relatives.
(2) A decline in other cognitive abilities characterized by deterioration in judgement and thinking, such as planning and organizing, and in the general processing of information. Evidence for this should be obtained when possible from interviewing an informant, supplemented, if possible, by neuropsychological tests or quantified objective assessments. Deterioration from a previously higher level of performance should be established. The severity of the decline, with mild impairment as the threshold for diagnosis, should be assessed as follows:
Mild. The decline in cognitive abilities causes impaired performance in daily living, but not to a degree making the individual dependent on others. More complicated daily tasks or recreational activities cannot be undertaken.
Moderate. The decline in cognitive abilities makes the individual unable to function without the assistance of another in daily living, including shopping and handling money. Within the home, only simple chores are preserved. Activities are increasingly restricted and poorly sustained.
Severe. The decline is characterized by an absence, or virtual absence, of intelligible ideation. The overall severity of the dementia is best expressed as the level of decline in memory or other cognitiveabilities, whichever is the more severe (e.g. mild decline in memory and moderate decline in cognitive abilitiesindicate a dementia of moderate severity).
G2. Preserved awarenenss of the environment (i.e. absence of clouding of consciousness (as defined in F05,criterion A)) during a period of time long enough to enable the unequivocal demonstration of G1. When there are superimposed episodes of delirium the diagnosis of dementia should be deferred.
G3.
A decline in emotional control or motivation, or a change in social behaviour, manifest as at least one of the following:
(1) emotional lability;
(2) irritability;
(3) apathy; (4) coarsening of social behaviour.
G4. For a confident clinical diagnosis, G1 should have been present for at least six months; if the period since the manifest onset is shorter, the diagnosis can only be tentative.
Comments: The diagnosis is further supported by evidence of damage to other higher cortical functions, such as aphasia, agnosia, apraxia.
Judgment about independent living or the development of dependence (upon others) need to take account of the cultural expectation and context.
Dementia is specified here as having a minimum duration of six months to avoid confusion with reversible states with identical behavioural syndromes, such as traumatic subdural haemorrhage (S06.5), normal pressure hydrocephalus (G91.2) and diffuse or focal brain injury (S06.2 and S06.3).
ICD 10
F00 DEMENTIA IN ALZHEIMER'S DISEASE
A. The general criteria for dementia (G1 to G4) must be met. B. There is no evidence from the history, physical examination or special investigations for any other possible cause of dementia (e.g. cerebrovascular disease, Parkinson's disease, Huntington's disease, normal pressure hydrocephalus), a sysytemic disorder (e.g. hypothyroidism, vit. B12 or folic acid deficiency, hypercalcaemia), or alcohol-or drug-abuse.
Comments: The diagnosis is confirmed by post mortem evidence of neurofibrillary tangles and neuritic plaques in excess of those found in normal ageing of the brain.
The following features support the diagnosis, but are not necessary elements: Involvement of cortical functions as evidenced by aphasia, agnosia or apraxia; decrease of motivation and drive, leading to apathy and lack of spontaneity; irritability and disinhibition of social behaviour; evidence from special investigations that there is cerebral atrophy, particularly if this can be shown to be increasing over time. In severe cases there may be Parkinson-like extrapyramidal changes, logoclonia, and epileptic fits.
Specification of features for possible subtypes. Because of the possibility that subtypes exist, it is recommended that the following characteristics be ascertained as a basis for a further classification: age at onset; rate of progression; the configuration of the clinical features, particularly the relative prominence (or lack) of temporal, parietal or frontal lobe signs; any neuropathological or neurochemical abnormalities, and their pattern.
The division of AD into subtypes can at present be accomplished in two ways: first by taking only the age of onset and labeling AD as either early or late, with an approximate cut-off point at 65 years
ICD 10
F01 VASCULAR DEMENTIA G1. The general criteria for dementia (G1 to G4) must be met. G2. Unequal distribution of deficits in higher cognitive functions, with some affected and others relatively spared. Thus memory may be quite markedly affected while thinking, reasoning and information processing may show only mild decline. G3. There is clinical evidence of focal brain damage, manifest as at least one of the following:
(1) unilateral spastic weakness of the limbs;
(2) unilaterally increased tendon reflexes;
(3) an extensor plantar response; (4) pseudobulbar palsy.
G4. There is evidence from the history, examination, or tests, of a significant cerebrovascular disease, which may reasonably be judged to be etiologically related to the dementia (e.g. a history of stroke; evidence of cerebral infarction). for dementia care.The need is to identify and support the needs of home-based care. Encourage the family to access/take help from out reach services like community health workers like ASHAs /volunteers of palliative care services .They may contact local chapters of Alzhiemer's and Related Disorders Society, Help Age India,Paliative Care Networks, other voluntary agencies engaged in geriatric care and seek support and guidance • Institutional care: When the hom-based care is not feasible or unavailable ,the person with dementia may need instituitional care with provision for assisted living • Short-term hospitalization : This is often required when there is a medical or surgical morbidity which often cannot be handled in ambulatory care settings. Onset of delirium or sudden worsening of BPSD also could necessitate brief hospitalization. Brief hospitalisations can be used to provide more information and assistance to caregivers. This can be an opportunity to identify unmet care needs as well as needs of the caregivers. • Long-term assisted living. There is a need for this facility especially when the home-based care is not able to meet the demands of care.This is a reality in many household as the family size is dwindling and most young people work outside their homes.
Consensus criteria for FRONTOTEMPORAL DEMENTIA
Non-pharmacological interventions
Non-pharmacological management strategies ( Table -8 ) have an important role in the management of dementia of any type. It is particularly helpful in elderly patients who may not tolerate pharmacological agents due to the development of adverse effects even in smaller doses. There are specific non-pharmacological interventions targeting the cognitive as well as non-cognitive symptoms and challenging behaviours seen in dementia.
• Non-pharmacological interventions for cognitive symptoms
People with mild to moderate dementia of all types should be encouraged to participate in structured cognitive stimulation programmes. They benefit cognition in such patients irrespective of whether any drug is prescribed or not. They are also beneficial in improving and maintaining their functional capacity. This is based on the view that lack of cognitive activity hastens cognitive decline. Reality orientation and reminiscence therapy is of use in this regard.
• Non-pharmacological interventions for non-cognitive symptoms and challenging behaviour
Non-cognitive symptoms and challenging behaviors significantly increase the burden of care. They lead to caregiver distress and burnout and hence is an important concern in the management of dementia. • Look for emergence of Behavioral Symptoms • Assess Caregiver Burden / Distress and look for unmet caregiver needs 
PROVIDE INFORMATION AND EDUCATION
Ask people assessed with dementia whether they wish to know the diagnosis and with whom it should be shared.
• Provide simple explanations of the illness which they can understand. • Give only basic information.
Key Messages to be communicated to the caregivers and the family : • Dementia is an illness of the brain and that usually tends to get worse over time. • Most conditions that cause dementia are irreversible and thus complete cure is not possible. But we can do many things help the person and the family. Guidance will help to address issues that can arise during dementia care. Providing support for home based care is important. Identify and provide information and education t to primary caregiver/s
Promote Activities of Daily living (ADLs) and
Participation in Social Activities • Encourage independent activity as much as possible. Assistance could be needed at times. But, encourage the person to engage in ADLs with guidance. Offer assistance and encourage to do the activity with assistance rather than "doing the task for the person". This will enhance functional ability and will allow preservation and maintenance of skills. This is an important principle. • Facilitate social interaction and participation in community activities. This will help to improve the quality of life of people with dementia and their corers. Instruct the caregivers to be socially active and remain networked with friends and other family members. They should try and actively prevent getting socially isolated • Give advice to maintain independent toileting skills • Keep the environment at home safe to reduce the risk of fall / injury. 
5.
Offer support for Caregivers.
• Assess current care arrangements.
• Identify the main caregivers and assess the impact of caregiving. • Look for caregiver distress ; look for depressive symptoms in the caregiver • Acknowledge that carers often experience difficulties during the care of people with dementia and that that stress is a common experience. • Encourage the care givers to seek help and support when they experience difficulty or strain • Provide adequate information about dementia and dementia care to all caregivers. Use leaflets hand outs for informing careers and their families • Provide specific information and guidance to manage behavioral symptoms, issues related to incontinence and co-morbid medical problems. • Advise caregivers to get support whenever feasible. • Encourage the option of getting another caregiver to substitute the primary caregiver periodically. This will allow relief to the primary caregiver who then can engage in other activities. • Explore whether the person qualifies for any disability benefits or other social/financial support (government or non-governmental).
treatment of dementia after comprehensive evaluation to understand the possible subtype, associated behavioural and psychological symptoms, comorbidity etc • Treatment of dementia needs to be focused on improving the cognitive function, amelioration of associated behavioral and psychological symptoms and improvement or stabilization of global functioning in daily activities. • It would be useful to have clear understanding of the treatment targets and proper monitoring of outcomes following treatment to optimize the treatment appropriately( Figure-9 ).
• Behavioral and psychosocial interventions are required
for all patients with dementia. Pharmacological treatment needs to be planned in addition to this particularly for behavioral and psychological symptoms of dementia.
Figure-9
Pharmacological treatment for cognitive symptoms of Dementia (Tables 9 & 10) • Alzheimer's disease is the most common cause of dementia and a major contributor for global disease burden. Hence there has been very active global effort to develop effective disease modifying drug for Alzheimer's disease in the past decade. • However, no new effective drug has been identified for improving the cognitive function in patients with dementia due to Alzheimer's disease in the last decade.
• Cholinesterase Inhibitors (Donepezil, Rivastigmine and
Galantamine) and NMDA antagonist (Memantine) are the approved pharmacological treatment options for the cognitive impairment in Alzheimer's Dementia • Donepezil has been approved for all stages of Alzheimer's dementia. Rivastigmine and Galantamine has been approved for mild to moderate Alzheimer's dementia • Memantine has been approved for moderate to severe Alzheimer's dementia • Combination of Donepezil and Memantine has been approved for moderate to Severe Alzheimer's dementia • Rivastigmine Transdermal patch (4.6mg, 9.5mg or 13,3mg per 24 hours) has been approved for mild to moderate Alzheimer's dementia. The extent of adverse effects with Rivastigmine is lesser in transdermal patch than oral formulation.
• There is no clear evidence regarding the benefit of Cholinesterase inhibitors for the management of behavioral and psychological symptoms in Alzheimer's dementia.
• The efficacy of cholinesterase inhibitors is established
clearly in the short term randomized controlled trials lasting for 3 to 6 months for the cognitive domains and global functioning. Pharmacological Treatment of Mild Cognitive Impairment • Mild Cognitive Impairment (MCI)is the high-risk state for dementia with significantly increased risk for conversion to dementia compared to those with normal cognition.
Older people with dementia have high risk of development delirium. Both hypoactive and hyperactive delirium can occur , but hypoactive delirium is more likely. Any sudden deterioration in sensorium ,activity level, behaviour should alert the possibility of superimposed delirium. It will be be associated with disturbance in sleep wake cycle and could also take the form of increased sleepiness.
• How to manage?
The management should involve attempts to identify multiple causes which usually contribute to development and persistence of delirium .Once identified these factors may be addressed and the condition be monitored. Disappearance of recent onset behavioural symptoms and improvement in cognitive functions over a period of days would usually be indicative of resolution of superimposed delirium 2. Management of Multi-morbidity. Dementia is a major neuropsychiatric condition and longterm medical care. Multimorbidity is common among older people and people with dementia are no exception. Two strategies can help here. The first one is to evaluate the person in detail for presence of co-morbidity and sensory impairments.This can be done after making the diagnosis of dementia. Do enquire about the current management of each problem. You may include the management of the comorbid conditions also into the follow-up plan.The second important strategy would be to be on the watch out for emergence of new problems like delirium or issues related falls , infections, cerebrovascular events etc. Prompt identification and early interventions can help to prevent or identify major eventsearly. Adherence to interventions is a matter of concern as this would be dependent on the caregivers. Communication with the caregivers will have to be simple and might need to be repeated. Try to speak to the primary caregivers directly and allow time for clarifications if they have doubts. Ask a family member to take up the responsibility of co-ordinating and monitoring home-based care and to report the progress during follow up visit. The primary caregiver is the ideal person to do this. Frequent changes in place/caregivers etc can create issues and is best avoided minimised. But resource limitations are frequent and providing more caregiver support during trying times can be a great help for families involved in dementia care 3. Risk of Falls/fractures : Prevention of accidents/trauma particularly falls is important. Judicious modification of the home environment will help. An informed caregiver can discuss this and do the needful. Discussions with caregivers and other family members will allow innovations which will may suit the particular home setting. All falls increase the risk of fractures and a fracture hip can have a very negative outcome for an older person with dementia 
CONCLUSIONS
Caregiver support and non-pharmacological interventions to manage symptoms like BPSD are the main ingredients of dementia care. Psychosocial management forms the first line and shall be given to all with BPSD. Psychosocial interventions work best when it is contextualized to the socio-cultural environment and the setting of care. Family and professional caregivers should be considered as key collaborators. Provision of relevant information , education and seamless support to caregivers , will be very crucial in dementia care. There is unmet need for such help and guidance .The families engaged in the care of a person affected by dementia will benefit from such support and this is especially so there are behavioral symptoms which are difficult to mange in home setting Some may benefit from pharmacological interventions but this shall be provided under supervision and needs to be monitored.
